The Clinical Feasibility and Validity of PMIvent to Access Inspiratory Effort During Pressure Support Ventilation
1 other identifier
interventional
25
1 country
1
Brief Summary
It is critical to maintain a relatively normal inspiratory effort during pressure support ventilation (PSV), the support level should be adjusted to match the patient's inspiratory effort. The inspiratory muscle pressure index (PMI) can reflect the elastic work of the respiratory system at the end of inspiration and has a significant correlation with inspiratory effort, and it has the outgoing advantages of being non-invasive and easy to obtain. Previous studies on PMI were based on physiological research and experimental conditions (PMIref), which require special pressure monitoring devices and software to collect and measure airway pressure. If PMI is going to be used in clinical practice, it is necessary to find a simple measurement method of PMI to replace PMIref. Most ventilators have airway pressure monitoring and end-inspiratory holding functions, and PMI can be measured by freezing the ventilator screen (PMIvent). The overall aim of this study was to determine PMIvent's clinical feasibility and validity for accessing inspiratory effort during PSV.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2023
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 25, 2023
CompletedFirst Submitted
Initial submission to the registry
July 1, 2023
CompletedFirst Posted
Study publicly available on registry
July 18, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
January 31, 2025
CompletedJuly 25, 2024
July 1, 2024
1.8 years
July 1, 2023
July 23, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Agreement of PMIvent and PMIref
The accuracy of PMIvent compared to PMIref was assessed by a Bland-Altman plot for each ventilator.
3 hours
Secondary Outcomes (2)
Correlation of inspiratory effort and PMIvent
3 hours
The predicted value of PMIvent for low/high effort
3 hours
Study Arms (1)
Experimental
EXPERIMENTALPMI represents the difference between plateau airway pressure and peak airway pressure (plateau - peak) during an end-inspiratory airway occlusion.
Interventions
Baseline ventilators were set by the principle of keeping VT/PBW at 6-8ml/kg and RR at 20-30 breaths/min and the decision of the responsible ICU physician. After then the fraction of inspired oxygen (FiO2), positive expiratory end pressure (PEEP), trigger sensitivity, and cycle-off criteria remain unchanged. Downward PS level titration was performed from 20 cmH2O to 2 cmH2O at a 2cm H2O interval. Every PS level was maintained for 20 minutes and then three end-inspiratory holdings (2-3seconds) and three end-expiratory holdings were performed. To avoid additional injury to the lung and diaphragm, the airway peak pressure (Ppeak) was limited to 30cmH2O.Inspiratory effort is measured as pressure generated by inspiratory muscles using esophageal pressure monitoring.
Eligibility Criteria
You may qualify if:
- Adult acute respiratory failure patients undergoing mechanical ventilation were screened daily and enrolled 24 hours after switching to PSV mode
You may not qualify if:
- age younger than 18 years old or older than 85 years
- known pregnancy and parturient
- chronic occlusive pulmonary diseases
- gastric, esophageal injury
- barotrauma
- diaphragm dysfunction
- intracranial hypertension and brain stem injury
- consciousness level decreased (RASS less than -2 scores)
- Anticipating withdrawal of life support and/or shift to palliation as the goal of care.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Jian-Xin Zhoulead
Study Sites (1)
Beijing Tiantan Hospital
Beijing, China
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
July 1, 2023
First Posted
July 18, 2023
Study Start
March 25, 2023
Primary Completion
December 31, 2024
Study Completion
January 31, 2025
Last Updated
July 25, 2024
Record last verified: 2024-07
Data Sharing
- IPD Sharing
- Will not share